| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10964445 | Vaccine | 2015 | 7 Pages |
Abstract
Our studies are proof of principle that inactivated GD-G-12 might be a novel vaccine candidate to prevent CAV infection, and highlight the utility of using an inactivated virus for this vaccine.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Xinheng Zhang, Boliang Wu, Yuanjia Liu, Weiguo Chen, Zhenkai Dai, Yingzuo Bi, Qingmei Xie,